In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cognis Holding Luxembourg SARL

Latest From Cognis Holding Luxembourg SARL

Australia’s New South Wales Pumps In Funds To Grow Medical Device Industry

Australia’s New South Wales awarded grants totaling AU$10.3 million as part of a campaign to spur innovation among medical device companies. Chosen from 147 applicants, the grant recipients are Elastagen Pty. Ltd., Endoluminal Sciences Pty. Ltd., HEARworks Pty Ltd., mobiLIFE Pty. Ltd. and Saluda Medical.

Medical Device BioPharmaceutical

In Brief

Robinson steps up to drug production; no warning needed for St. John’s wort, CRN says; Iovate settles with Calif. counties; more In Brief

Consumer United States

Emergings In Brief (03/2011)

Brief profiles of these recently formed companies: 2C Tech Corp., Atherolysis Medical, Axena Technologies and Prevention Pharmaceuticals.

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2010

Highlights from the Q2 2010 review of pharmaceutical and biotechnology dealmaking: Biopharma companies raised a total of $3.4bn through 96 financings. Twenty-one acquisitions together reached $20.2bn, thanks to five deals each exceeding $3 billion - in aggregate accounting for 91% of the M&A total. The alliance volume was up to 115 transactions for a total of $2.8 billion in pre-commercialization money, with seven deals surpassing the $100 million mark.

See All

Company Information